RESUMEN
Objective: To evaluate the clinical benefits of Moses technology compared with the regular mode with the Lumenis® Pulse™ P120H holmium laser during ureteroscopy for stone disease. Patients and Methods: An IRB-approved database of patients with urolithiasis was analyzed for ureteroscopies from January 2020 to December 2020 at an outpatient surgery center. Patients who underwent ureteroscopy with the Lumenis Pulse P120H holmium laser system with the Moses or regular mode were included. Patient characteristics and stone parameters were collected. Operative room parameters were compared, including procedural time, fragmentation/dusting time, lasing time, and total energy used. Complication rates and stone-free rates were also analyzed. Univariate analysis and multiple analysis of covariance controlling for cumulative stone size were performed. Patients with staged procedures were excluded. Results: Of 197 surgical cases, 176 met the inclusion criteria. Moses was utilized in 110 cases and regular mode in 66. There was no difference in cumulative stone size between Moses and regular modes (11.8 ± 7.9 vs 11.6 ± 9.2 mm, p = 0.901). Procedural time (43.5 ± 32.1 vs 39.8 ± 24.6 minutes, p = 0.436), fragmentation/dusting time (20.5 ± 25.3 vs 17.1 ± 16.1 minutes, p = 0.430), lasing time (7.5 ± 11.1 vs 6.7 ± 7.9 minutes, p = 0.570), and total energy used (5.1 ± 6.7 vs 3.8 ± 4.8 kJ, p = 0.093) were also similar. Complications (6.4% vs 6.1%, p = 0.936) and stone-free rates (52.3% vs 65.3%, p = 0.143) did not differ. Conclusion: At our institution, Moses technology did not significantly change the procedural time, fragmentation/dusting time, lasing time, or total energy used. Moreover, there were no differences in complications or stone-free rates. There may be technical benefits to the Moses technology not captured in this analysis.
Asunto(s)
Cálculos Renales , Láseres de Estado Sólido , Litotripsia por Láser , Cálculos Ureterales , Humanos , Cálculos Renales/cirugía , Litotripsia por Láser/métodos , Tecnología , Resultado del Tratamiento , Cálculos Ureterales/cirugía , UreteroscopíaRESUMEN
Management options for small renal masses include active surveillance, partial nephrectomy, radical nephrectomy, and thermal ablation. For tumors typically ≤3 cm in size, thermal ablation is a good option for those desiring an alternative to surgery or active surveillance, especially in patients who are considered high surgical risk. We favor microwave ablation because of the more rapid heating, higher temperatures that overcome the heat sink effect of vessels, reproducible cell kill, and a highly visible ablation zone formed by water vapor that corresponds well to the zone of necrosis. For central tumors, we favor cryoablation because of the slower formation of the ablation zone and less likelihood of damage to the collecting system. With microwaves, it is important to monitor the ablation zone in real time (ultrasound is the best modality for this purpose), avoid direct punctures of the collecting system, and to place probes tangential to the collecting system to avoid burning open a persistent tract between the urothelium and extrarenal spaces or causing strictures. The surgical steps described in this video cover our use of high-frequency jet ventilation with general anesthesia to minimize organ motion, initial imaging and targeting, probe insertion, hydrodissection (a technique that enables displacement of adjacent structures), the ablation itself, and finally our dressing. Postoperative cares typically consist of observation with a same-day discharge or an overnight stay. Follow-up includes a magnetic resonance imaging abdomen with and without contrast, chest X-ray, and laboratories (basic metabolic panel, complete blood count, and C-reactive protein) 6 months postablation. Overall, percutaneous microwave ablation is an effective and safe treatment option for renal cell carcinoma in both T1a and T1b tumors in selected patients with multiple studies showing excellent oncologic outcomes when compared with partial and radical nephrectomy.
Asunto(s)
Carcinoma de Células Renales , Neoplasias Renales , Carcinoma de Células Renales/diagnóstico por imagen , Carcinoma de Células Renales/cirugía , Humanos , Neoplasias Renales/diagnóstico por imagen , Neoplasias Renales/cirugía , Microondas/uso terapéutico , Nefrectomía , Resultado del TratamientoRESUMEN
INTRODUCTION The objective of this study is to explore the association between urinary stone composition and surgical recurrence. MATERIALS AND METHODS: Patients who underwent kidney stone surgeries (between 2009-2017), were followed for > 1 year, and had ≥ 1 stone composition analyses were included in our analysis. Surgical stone recurrence (repeat surgery) was defined as the second surgery on the same kidney unit. Recurrence-free survival analysis was used. RESULTS: A total number of 1051 patients were included (52.7% men, average age 59.1 +/- 15.1 years). Over 4.7 +/- 2.5 years follow up, 26.7% of patients required repeat surgery. Patients' stone compositions were calcium oxalate (66.0%), uric acid (12.2%), struvite (10.0%), brushite (5.7%), apatite (5.1%) and cystine (1.0%). Results suggested that patients with cystine stones had the highest surgical recurrence risk; brushite had the second-highest surgical recurrence risk. Struvite, uric acid, and apatite stones were at higher risk compared with calcium oxalate stones (lowest risk in our cohort). When pre and postoperative stone size was controlled, patients with a history of uric acid, brushite, and cystine stones were at higher surgical risk. After controlling clinical and demographic factors, only brushite and cystine stones were associated with higher surgical recurrence. CONCLUSIONS: Patients with cystine stones had the highest surgical recurrence risk; brushite stones had the second highest surgical recurrence risk. Struvite, uric acid, and apatite stones were at higher risk compared with calcium oxalate stones. When pre and postoperative stone size, clinical and demographic factors were controlled, only those with brushite or cystine stones were at significantly higher risk of surgical recurrence.
Asunto(s)
Cálculos Renales , Cálculos Urinarios , Adulto , Anciano , Oxalato de Calcio , Femenino , Humanos , Cálculos Renales/cirugía , Masculino , Persona de Mediana Edad , Estruvita , Ácido Úrico , Cálculos Urinarios/cirugíaRESUMEN
Objectives: To determine the safety and efficacy of flexible ureteroscopy in the treatment of transplant urolithiasis. Materials and Methods: We reviewed a single-center series of 2652 patients who underwent surgical treatment for nephrolithiasis at our institution from 2009 to the present day to identify all patients undergoing ureteroscopy for treatment of transplant lithiasis. Results: We identified 18 patients who underwent ureteroscopy for treatment of urolithiasis within the transplanted kidney or ureter. The majority of the procedures were performed using a retrograde approach with flexible ureteroscopy, with one patient undergoing antegrade ureteroscopy and two patients requiring semirigid ureteroscopy. Holmium:yttrium-aluminum-garnet laser lithotripsy was utilized in all but one case, which was performed using basket extraction. There were no intraoperative complications reported. Four patients had small stone fragments on postoperative imaging, three of which were observed. One patient required repeat ureteroscopy for persistent distal ureteral stone. Conclusion: Retrograde ureteroscopy is a feasible, safe, and effective intervention for the treatment of transplant lithiasis. Minimal intraoperative or postoperative complications were reported, and only one patient required additional intervention for residual stone burden.
Asunto(s)
Cálculos Renales , Trasplante de Riñón , Litotripsia por Láser , Cálculos Ureterales , Urolitiasis , Humanos , Estudios Retrospectivos , Resultado del Tratamiento , Ureteroscopía , Urolitiasis/cirugíaRESUMEN
OBJECTIVE: To determine if socioeconomic status (SES) correlates with severity of kidney stone disease and 24-hour urine parameters. MATERIALS AND METHODS: An IRB approved prospectively maintained database for nephrolithiasis was retrospectively analyzed for both 24-hour urine results and surgical procedures performed from 2009 to 2019. Severely distressed communities (SDC) were categorized as those with a Distressed Communities Index (DCI), a composite measure of SES, score in the top quartile (lowest for SES). Univariate and multivariate analyses were performed to evaluate the strength of the association of DCI on: stone size at presentation, need for and type of surgical procedure, need for staged surgery and specific stone risk factors in 24-hour urine collections. RESULTS: Surgical procedures were performed on 3939 patients (1978 women) who were not from SDC and 200 (97 women) from SDC. Patients from SDC were older (57.1 years vs 54.2 years; P = .009). Patients from SDC were more likely to undergo proportionally more invasive procedures (17.5% vs 11.6%; P = .011) and require staged surgery at a higher rate (13.0% vs 8.5%; P = .028). Men from SDC had larger stones (12.5 mm vs 9.7 mm; P = .001). Among 24-hour urine results from 2454 patients (1187 women), DCI was not correlated with sodium, calcium, magnesium, volume, oxalate, phosphate, and pH levels. Higher DCI (lower SES) correlated with lower urine citrate (P = .001) and lower urine potassium (P = .002). CONCLUSION: SES correlates with larger stone burden at the time of urologic intervention, requires proportionally more invasive procedures and more staged procedures. Lower SES correlated with lower urine citrate and potassium.
Asunto(s)
Cálculos Renales/cirugía , Cálculos Renales/orina , Adulto , Anciano , Biomarcadores/orina , Correlación de Datos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Clase SocialRESUMEN
Objectives: Influence of renal anatomy on success rates for shockwave lithotripsy has been reported in the literature with emphasis on lower pole anatomy. Influence of renal anatomy has not been evaluated in the setting of ureteroscopy and laser lithotripsy for stone treatment. This study analyzed the influence of infundibulopelvic angle (IPA) of the lower pole on the outcomes of ureteroscopy and laser lithotripsy with respect to stone-free rate and surgical recurrence. Materials and Methods: We retrospectively analyzed 735 renal units undergoing retrograde flexible ureteroscopy (fURS) with laser lithotripsy between January 2009 and December 2016. All cases were performed at a single institution. No exclusion criterion was applied with regard to preoperative stone location. Success was defined as no evidence of residual stone fragments on kidney, ureter, and bladder radiograph within 2 months of surgery. Failure was defined as any stone present on imaging. Lower pole IPA was measured on intraoperative retrograde pyelogram as described by Elbahanasy et al. Univariate and multivariate analyses of factors contributing to stone-free rate were performed. Secondary outcomes included surgical recurrence-free survival. Results: Of the 735 cases evaluated, 243 cases had a retrograde pyelogram stored in our Picture Archiving and Communication System (PACS) sufficient for IPA interpretation. Of these patients, 122 (50%) were women. In total, 127 patients (52.3%) were stone free on follow-up imaging, whereas 116 (47.7%) had residual stone burden. In total, 144 (59%) patients had ≤3 mm stone burden on follow-up imaging. In multivariate analysis, residual stone fragments were significantly associated with acute IPA <90° (<0.001), lower pole stones preoperatively (<0.001), and larger stone size (0.001). IPA <90° and larger stone size were both found to be statistically significantly associated with need for repeat surgery. Conclusions: Our data show that more acute IPA and larger preoperative stone size negatively affect stone-free rate and need for repeat surgery after retrograde fURS with laser lithotripsy for treatment of renal stones.
Asunto(s)
Cálculos Renales , Litotripsia por Láser , Litotricia , Femenino , Humanos , Cálculos Renales/cirugía , Masculino , Recurrencia Local de Neoplasia , Estudios Retrospectivos , Resultado del Tratamiento , UreteroscopíaRESUMEN
OBJECTIVE: To compare perioperative and oncologic outcomes for patients with clinical T1b renal cell carcinoma following treatment with microwave ablation (MW), partial nephrectomy (PN), or radical nephrectomy (RN). METHODS: Comprehensive clinical and pathologic data were collected for nonmetastatic renal cell carcinoma patients with cT1b tumors following MW, PN, or RN from 2000 to 2018. Local recurrence-free, metastasis-free, cancer-specific and overall survival were estimated using Kaplan-Meier method. Prognostic factors for complications and survival were determined using logistic regression and Cox hazard models, respectively. RESULTS: A total of 325 patients (40 MW, 74 PN, and 211 RN) were identified. Patients treated with MW were older with higher Charlson comorbidity indices compared to surgical patients. Median length of hospitalization was shorter for MW compared to surgical patients (1 day vs 4 days, P <.0001). Post-treatment estimated glomerular filtration rate decreased by median 4.5% for MW compared to 3.2% for PN (Pâ¯=â¯.58) and 29% for RN (P <.001). Median follow-up was 34, 35, and 49 months following MW, PN, and RN, respectively. Estimated 5-year local recurrence-free survival was 94.5% for MW vs 97.9% for PN (Pâ¯=â¯.34) and 99.2% for RN (Pâ¯=â¯.02). Two patients recurred after MW and underwent repeat ablation without subsequent recurrence. No difference in 5-year metastasis-free survival or cancer-specific survival was found among MW, PN, or RN. Four (10%) MW patients had high-grade complication. Only prior abdominal surgery predicted high-grade complication (OR 6.29, Pâ¯=â¯.017). CONCLUSION: Microwave ablation is a feasible alternative to surgery in select comorbid patients with clinical T1b renal cell carcinoma.
Asunto(s)
Carcinoma de Células Renales/cirugía , Neoplasias Renales/cirugía , Recurrencia Local de Neoplasia/cirugía , Nefrectomía/efectos adversos , Complicaciones Posoperatorias/epidemiología , Ablación por Radiofrecuencia/efectos adversos , Anciano , Carcinoma de Células Renales/mortalidad , Supervivencia sin Enfermedad , Estudios de Factibilidad , Femenino , Estudios de Seguimiento , Tasa de Filtración Glomerular , Humanos , Estimación de Kaplan-Meier , Neoplasias Renales/mortalidad , Masculino , Microondas/uso terapéutico , Persona de Mediana Edad , Recurrencia Local de Neoplasia/epidemiología , Recurrencia Local de Neoplasia/prevención & control , Estadificación de Neoplasias , Nefrectomía/métodos , Complicaciones Posoperatorias/etiología , Ablación por Radiofrecuencia/métodos , Reoperación/estadística & datos numéricosRESUMEN
OBJECTIVE: We present our experience of the treatment of reservoir stones using a percutaneous approach in patients with Indiana pouch urinary diversions. MATERIAL AND METHODS: Patients who were treated percutaneously for Indiana pouch reservoir stones between January 2008 and December 2018 were identified from the hospital database, and their data were retrospectively analyzed. Patient charts were reviewed for stone burden, surgery details, and postoperative complications. The Indiana pouch was punctured under a direct ultrasound guidance, and a 30F sheath was placed into the pouch. A urologist removed the stones by inserting a rigid nephroscope through the sheath. A Foley catheter was left in the pouch through the percutaneous tract and opened to drainage. RESULTS: Seven patients (mean age: 47.3±14.7 years) were included. All patients were stone free after the procedure. The median stone number was 3 (range: 1-8). The mean maximum stone diameter was 24.4±4.9 mm (range: 19-33 mm). Six patients were successfully treated in one session, whereas 1 patient required two treatment sessions. The median postoperative hospital admission was 1 day (range: 1-5 days). The Foley catheters were removed after a median of 18 days (range: 10-19 days). No major complications were reported. CONCLUSION: The percutaneous approach for Indiana pouch reservoir stones treatment ensures direct and safe management without major periprocedural complications.
RESUMEN
OBJECTIVE: To analyze risk factors and patterns of RCC recurrence following percutaneous ablation for stage 1 tumors and develop risk-stratified follow-up imaging protocols. METHOD: Biopsy-proven sporadic stage 1 RCC patients treated with percutaneous microwave ablation (MWA) or cryoablation (CA) from 2002 to 2017 were included. Kaplan-Meier analysis was used to estimate local and distant recurrence-free survival, cancer-specific survival and metastatic-free survival. Multivariable models were used to identify risk factors associated with recurrence. RESULTS: A total of 256 patients with stage 1 RCC (215 T1a, 41 T1b) were treated with percutaneous MWA (178 subjects) or CA (78 subjects). Recurrence was identified in 23 patients (16 local, 7 distant). Clinical T stage (HR 2.46, 95% CI 1.06-5.72, Pâ¯=â¯.04) and tumor grade (HR 4.17, 95% CI 1.17-14.76, Pâ¯=â¯.03) were independent predictors of recurrence. Recurrence was not associated with Nephrometry score, cystic tumors, ablation modality (CA vs MWA) or gender. Five-year cancer-specific survival, and metastatic-free survival were 98.6% and 97.4%, respectively. Patients were stratified into 2 groups: reduced risk stage 1 (no risk factors) or elevated risk stage 1 (≥1 risk factor). Recurrence risk was higher in the elevated-risk group (HRâ¯=â¯3.19, 95% CI 1.35-7.53, Pâ¯=â¯.008). Five-year overall recurrence-free survival (localâ¯+â¯distant) was higher in reduced-risk vs elevated-risk cohorts, 88% vs 69%, Pâ¯=â¯.005. CONCLUSION: High nuclear grade or T1b tumors have increased recurrence risk following percutaneous thermal ablation for stage 1 RCC. Current postablation follow-up protocols may be modified for individual recurrence risk to allow more frequent imaging for elevated-risk patients, while enabling less frequent imaging for reduced-risk patients.
Asunto(s)
Técnicas de Ablación , Carcinoma de Células Renales/cirugía , Criocirugía , Neoplasias Renales/cirugía , Microondas/uso terapéutico , Medición de Riesgo , Anciano , Carcinoma de Células Renales/diagnóstico por imagen , Carcinoma de Células Renales/mortalidad , Carcinoma de Células Renales/patología , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Renales/diagnóstico por imagen , Neoplasias Renales/mortalidad , Neoplasias Renales/patología , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Modelos de Riesgos Proporcionales , Terapia por Radiofrecuencia , Estudios Retrospectivos , Factores de Riesgo , Tomografía Computarizada por Rayos XRESUMEN
OBJECTIVE: To identify the clinical and demographic predictors of repeat stone surgery. MATERIALS AND METHODS: We retrospectively analysed 1496 consecutive patients, aged > 18 years, who underwent stone surgery at our institution in the period from January 2009 to May 2017 and who had at least 12 months of postoperative follow-up. We defined surgical recurrence as repeat surgery on the same renal unit or on the opposite renal unit if the original imaging did not demonstrate significant stones on that side. Characteristics associated with the risk of surgical recurrence in univariate Cox regression analysis were entered into a multivariate model. RESULTS: Most patients underwent ureteroscopy and laser lithotripsy (83.0%). Approximately 60% of the patients had a personal history of stone disease and 50% were obese. Over a mean (median; interquartile range) follow-up of 4.1 (3.9; 2.4-5.9) years, 24.5% of patients had surgical recurrence, with 82% of repeat surgeries performed for symptomatic nephrolithiasis. The factors associated with increased risk of surgical recurrence in the multivariate model were: age <60 years, female gender, malabsorptive gastrointestinal disease, diabetes, recurrent urinary tract infections, personal history of nephrolithiasis, renal stones and bilateral nephrolithiasis. The hazard ratios for these variables ranged within an interval of <0.5 (from 1.30 to 1.71). CONCLUSION: We identified eight demographic and clinical factors associated with increased risk of repeat renal stone surgery. These factors could be combined as a numerical count that allows stratification of patients into low-, intermediate- and high-risk subgroups.
Asunto(s)
Litotricia , Nefrolitiasis , Reoperación/estadística & datos numéricos , Ureteroscopía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Litotricia/efectos adversos , Litotricia/métodos , Litotricia/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Nefrolitiasis/epidemiología , Nefrolitiasis/cirugía , Estudios Retrospectivos , Factores de Riesgo , Ureteroscopía/efectos adversos , Ureteroscopía/estadística & datos numéricos , Adulto JovenRESUMEN
Objective: To assess the performance of recurrence of kidney stone (ROKS) nomogram in identifying first-time stone formers who will require future stone procedures. Materials and Methods: From January 2009 to February 2016, 2287 patients underwent surgical treatment for nephrolithiasis at our institution and 498 of them were eligible for this study. We defined recurrence as repeat surgery for symptomatic nephrolithiasis. We analyzed the performance of the nomogram with respect to discrimination, calibration, and the clinical net benefit. We also examined the performance of each individual variable from the nomogram. Results: Over a median follow-up of 4.8 years (mean 4.6, IQR 3.1-6.1), 88 patients (17.7%) had recurrent nephrolithiasis requiring surgical treatment. The ROKS nomogram demonstrated moderate discriminative ability (AUC 0.655 for 2 years and 0.605 for 5 years). Calibration of the ROKS nomogram-based predictions was poor and net clinical benefit was minimal. Three of 11 predictors from the nomogram were statistically significantly associated with the risk of repeat surgery, with two of them representing similar clinical scenarios, namely symptomatic and nonsymptomatic renal stones. Conclusion: ROKS nomogram demonstrated limited discrimination and calibration in predicting the risk of repeat surgery for symptomatic nephrolithiasis in our cohort of first-time stone formers. This may be caused by the differences between stone patients who do and do not require surgery and suggests the need for development of more precise prediction instruments.
Asunto(s)
Cálculos Renales/prevención & control , Cálculos Renales/cirugía , Nomogramas , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Calibración , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Probabilidad , Modelos de Riesgos Proporcionales , Recurrencia , Reproducibilidad de los Resultados , Riesgo , Prevención Secundaria , Adulto JovenRESUMEN
PURPOSE: We analyzed the impact of residual stone fragments seen on abdominal x-ray after ureteroscopy and laser lithotripsy on the risk of repeat surgical intervention. MATERIALS AND METHODS: Our study included 781 patients (802 renal units) who underwent ureteroscopy and laser lithotripsy with abdominal x-ray within 3 months postoperatively and who had at least 1 year of followup. Ureteroscopy and laser lithotripsy were performed using the dusting technique. We analyzed the association between surgical recurrence-free survival and the size of the largest residual fragment. RESULTS: During a median followup of 4.2 years repeat surgery was performed on 161 renal units (20%). Of the repeat interventions 75% were done for symptomatic nephrolithiasis. Postoperative imaging showed residual stone fragments in 42% of cases. In the entire group the risk of repeat surgery was increased in renal units with residual fragments greater than 2 mm. The effect of the size of residual fragments on the risk of surgical recurrence varied by patient body mass index. It was much larger in nonobese subjects, who were at increased risk for repeat surgery with residual fragments of any size. In the obese subgroup only fragments greater than 2 mm increased the risk of surgical recurrence. CONCLUSIONS: The association between the size of residual stone fragments detected by abdominal x-ray after ureteroscopy and laser lithotripsy, and the risk of repeat surgical intervention depends on patient body mass index. Nonobese patients with residual stone fragments of any size are at increased risk for repeat intervention compared to those with a negative abdominal x-ray. The predictive value of abdominal x-ray after ureteroscopy and laser lithotripsy is limited in obese patients.
Asunto(s)
Índice de Masa Corporal , Cálculos Renales/terapia , Litotripsia por Láser/efectos adversos , Reoperación/estadística & datos numéricos , Ureteroscopía/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Riñón/cirugía , Litotripsia por Láser/métodos , Masculino , Persona de Mediana Edad , Recurrencia , Estudios Retrospectivos , Factores de Riesgo , Resultado del Tratamiento , Ureteroscopía/métodos , Adulto JovenRESUMEN
PURPOSE: To evaluate the safety and efficacy of US-guided percutaneous microwave (MW) ablation in the treatment of renal angiomyolipoma (AML). MATERIALS AND METHODS: From January 2011 to April 2014, seven patients (5 females and 2 males; mean age 51.4) with 11 renal AMLs (9 sporadic type and 2 tuberous sclerosis associated) with a mean size of 3.4 ± 0.7 cm (range 2.4-4.9 cm) were treated with high-powered, gas-cooled percutaneous MW ablation under US guidance. Tumoral diameter, volume, and CT/MR enhancement were measured on pre-treatment, immediate post-ablation, and delayed post-ablation imaging. Clinical symptoms and creatinine were assessed on follow-up visits. RESULTS: All ablations were technically successful and no major complications were encountered. Mean ablation parameters were ablation power of 65 W (range 60-70 W), using 456 mL of hydrodissection fluid per patient, over 4.7 min (range 3-8 min). Immediate post-ablation imaging demonstrated mean tumor diameter and volume decreases of 1.8% (3.4-3.3 cm) and 1.7% (27.5-26.3 cm(3)), respectively. Delayed imaging follow-up obtained at a mean interval of 23.1 months (median 17.6; range 9-47) demonstrated mean tumor diameter and volume decreases of 29% (3.4-2.4 cm) and 47% (27.5-12.1 cm(3)), respectively. Tumoral enhancement decreased on immediate post-procedure and delayed imaging by CT/MR parameters, indicating decreased tumor vascularity. No patients required additional intervention and no patients experienced spontaneous bleeding post-ablation. CONCLUSION: Our early experience with high-powered, gas-cooled percutaneous MW ablation demonstrates it to be a safe and effective modality to devascularize and decrease the size of renal AMLs.
Asunto(s)
Angiomiolipoma/terapia , Ablación por Catéter/métodos , Neoplasias Renales/terapia , Microondas/uso terapéutico , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Esclerosis Tuberosa/terapia , Ultrasonografía Intervencional , Adulto JovenRESUMEN
PURPOSE: Percutaneous radiofrequency ablation and cryoablation are accepted alternative treatments for small renal cell carcinomas (RCC) in high-risk patients. The recent development of high-powered microwave (MW) ablation offers theoretical advantages over existing ablation systems, including higher tissue temperatures, more reproducible ablation zones, and shorter procedural times. The purpose of this study is to review the feasibility, safety, and early efficacy of a novel high-powered percutaneous MW ablation system to treat RCC. METHODS: An institutional database identified 53 consecutive patients with biopsy-proven RCC ≤4 cm (55 tumors) who were treated with percutaneous MW ablation using a novel MW ablation system. All patients had percutaneous renal mass biopsy, which identified RCC before ablation. Postprocedure follow-up imaging was performed by contrast-enhanced computed tomography or magnetic resonance imaging. RESULTS: Mean patient age was 66 years and 81% of patients were male. RCC subtypes included clear cell (n=25), papillary (n=12), and unspecified (n=18) and Fuhrman grades 1, 2, 3, and ungraded in 15, 25, 1, and 14 patients, respectively. The mean tumor diameter was 2.6 cm (range 0.8-4.0 cm). Six low-grade complications were recorded during 53 (11.3%) procedures: five Clavien Grade 1 (urine retention, fluid overload, and atrial fibrillation) and one Grade 2 (hemorrhage requiring transfusion). The postprocedure estimated glomerular filtration rate was not significantly changed from preprocedure levels (median: -1.1%, p=0.10). Median follow-up was 8 months (interquartile range [IQR] 5-18.25) with 0/38 (0%) patients demonstrating evidence of local recurrence or metastasis during surveillance imaging. CONCLUSIONS: Use of a high-powered MW ablation system for the treatment of T1a RCC is feasible, safe, and efficacious with short-term follow-up. A longer follow-up is warranted to evaluate oncologic outcomes.
Asunto(s)
Carcinoma de Células Renales/terapia , Neoplasias Renales/terapia , Microondas/uso terapéutico , Anciano , Biopsia , Carcinoma de Células Renales/patología , Estudios de Factibilidad , Femenino , Humanos , Neoplasias Renales/patología , Imagen por Resonancia Magnética , Masculino , Microondas/efectos adversos , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Seguridad , Resultado del TratamientoRESUMEN
BACKGROUND: Loss of a needle during laparoscopic surgery is a rare but potentially serious adverse event that can cause prolonged operative time and patient harm. Standard recovery techniques currently include instrument count, standard visual search, and plain abdominal x-rays. We developed a laparoscopic instrument to speed the retrieval of lost needles in the abdomen and pelvis. STUDY DESIGN: We performed in vivo testing of a novel articulating laparoscopic magnet in a porcine model. Three experienced surgeons and 3 inexperienced surgeons conducted 116 needle-retrieval trials with the device and 58 trials with a standard visual approach. Surgeons were blind to the locations of randomly placed surgical needles within the abdominal cavity. Time to recovery was measured and capped at 15 minutes. Analysis was performed using univariate and multivariable methods. RESULTS: The magnetic device was able to retrieve needles significantly faster than the standard approach (2.9 ± 4.0 minutes vs 8.0 ± 6.0 minutes; p < 0.0001). On multivariable analysis, faster recovery time remained independently significant when controlling for surgeon experience, needle size (small, medium, or large), and needle location (by quadrant) (p < 0.0001). There were 2 (2%) injuries to abdominal organs during the device trials and 4 (7%) injuries during the standard trials (p = 0.182). CONCLUSIONS: Recovery of lost surgical needles during porcine laparoscopic surgery is safe and feasible with a simple articulating magnetic device. Our initial in vivo experience suggests that recovery is markedly faster using the magnetic device than the standard approach, even in the hands of experienced laparoscopic surgeons. This device will be particularly useful as minimally invasive robotic and single-site surgical techniques are adopted and, in the future, it should be integrated into the standard protocol for locating lost needles during surgery.
Asunto(s)
Remoción de Dispositivos/instrumentación , Remoción de Dispositivos/normas , Laparoscopía/normas , Imanes , Procedimientos Quirúrgicos Mínimamente Invasivos/normas , Agujas , Mejoramiento de la Calidad , Abdomen/cirugía , Animales , Diseño de Equipo , Modelos Logísticos , Modelos Animales , PorcinosRESUMEN
PURPOSE: We aimed to determine the current practice patterns at academic institutions in the use of ablative technologies for the management of small renal masses. PATIENTS AND METHODS: Mail surveys were sent to 124 academic institutions in the United States. The survey consisted of 12 questions pertaining to institutional demographic information, the use of ablation technology for small renal masses, the role of the urologist in ablation, and biopsy preferences prior to treatment. RESULTS: The overall response rate was 52% (64/124). Ablation was offered by all of the academic centers that responded to the survey and included 73% percutaneous cryoablation, 52% percutaneous radiofrequency ablation, 83% laparoscopic cryoablation, and 20% laparoscopic radiofrequency ablation. Eighty-eight percent of institutions performed one to five total ablation procedures each month. Urologists alone performed 13% of ablation procedures, radiologists performed 45% of ablation procedures, and a combined approach (urologist and radiologist present) was used in 43% of the institutions. When questioned about their role during percutaneous ablation, we found that urologists were present at the time of ablation in 59% of institutions, in 32% of institutions urologists placed the needles for ablation, and in 98% of institutions urologists were responsible for the postoperative care of the patient. Eighty-nine percent of academic institutions performed a biopsy of the renal mass with 67% performing a core biopsy, 5% performing a fine-needle aspiration (FNA), and 28% performing both a core biopsy and FNA. Nineteen percent of institutions performed a renal mass biopsy prior to the day of the procedure so that the pathology was known prior to ablation. CONCLUSIONS: Ablative technologies are well utilized for the treatment of small renal masses at current academic institutions with urologists directly involved in the ablation procedure in only half of the institutions. While preablation biopsy is common, pathology is rarely known prior to ablation.
Asunto(s)
Centros Médicos Académicos/estadística & datos numéricos , Academias e Institutos/estadística & datos numéricos , Ablación por Catéter/métodos , Neoplasias Renales/epidemiología , Neoplasias Renales/cirugía , Pautas de la Práctica en Medicina/estadística & datos numéricos , Encuestas de Atención de la Salud/estadística & datos numéricos , Humanos , Estados Unidos/epidemiologíaRESUMEN
We describe our experience using an iodinated contrast solution to hydrodissect adjacent structures before percutaneous renal cryoablation. Hydrodissection was performed before cryoablation with placement of a 20-gauge, 15-cm introducer needle into the retroperitoneum under CT or ultrasonographic guidance followed by infusion of 5% dextrose in water and 2% iodinated contrast between the kidney and the adjacent organ. Ten patients underwent hydrodissection with an iodinated contrast solution at our institution. The mean tumor size was 3.1 ± 1.2 cm. The organs displaced included colon (n=7), small bowel (n=1), pancreas (n=1), and in one case, both the colon and ureter were displaced. The average displacement of all organs from the kidney was 2.8 cm (range 2.2-3.5 cm). There were no complications and no injuries to any adjacent structures. The injection of iodinated contrast allows for safe mobilization and differentiation of adjacent structures from the renal tumor and parenchyma leading to potentially safer cryoablation.
Asunto(s)
Medios de Contraste , Criocirugía/métodos , Disección/métodos , Yodo , Riñón/cirugía , Agua , Colon/cirugía , Humanos , Neoplasias Renales/cirugía , Páncreas/cirugíaRESUMEN
BACKGROUND AND OBJECTIVES: To evaluate outcomes for simple hand-assisted laparoscopic nephrectomy (HALSN). METHODS: A retrospective chart review was performed at our institution for all patients who had undergone HALSN from January 2002 to January 2009. Thirty-three patients underwent HALSN during this time period and were matched with 33 patients who underwent radical handassisted laparoscopic nephrectomy (HALRN). RESULTS: Operative times were similar between both groups (301 vs 286 min for HALSN vs HALRN; P=.54). There were no intraoperative or postoperative transfusions in either group. There was one conversion to open nephrectomy in the HALSN group in a patient with xanthogranulomatous pyelonephritis and no conversions in the HALRN group. The mean opioid equivalence requirement was not statistically different between both groups (110 vs 120 for HALSN vs HALRN, P=.70). Mean hospital stay was similar for patients undergoing HALSN and HALRN (5.0±3.8 days vs 4.0±1.2 days, P=.63). There was 1 major complication in the HALSN group (pulmonary embolus) and no major complications in the HALRN group. Rates of minor complications were comparable between the 2 groups (18% vs 24% for HALSN vs HALRN). CONCLUSIONS: HALSN may be associated with similar operative times and length of postoperative hospital stay as well as comparable complication rates compared to HALRN.
Asunto(s)
Laparoscópía Mano-Asistida/métodos , Enfermedades Renales/cirugía , Nefrectomía/métodos , Estudios de Factibilidad , Femenino , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
PURPOSE: Prior studies suggest poor long-term incorporation of laparoscopy into urology practice after a postgraduate course. We evaluated the influence of the American Urological Association Mentored Laparoscopy Course on urologist clinical practice. MATERIALS AND METHODS: The 2-day Mentored Laparoscopy Course includes lectures, standardized dry laboratory training with videotape analysis and a porcine laboratory with consistent mentors. Surveys to assess the impact of the course were sent in April 2010 to the 153 urologists who had taken the course from 2004 through 2009. RESULTS: Of the 153 surveys 91 (60%) were returned a mean of 34.5 months after completing the course. Of the respondents 82% were in a group private practice, followed by solo private practice (15%) and full-time academic practice (3%). Of the respondents 92% reported that they had sutured laparoscopically, 52% had sutured a bleeding vessel and 51% had performed reconstructive laparoscopy since taking the course. Of the respondents 77% reported that their laparoscopic practice had expanded since taking the course (mean 2.9 cases monthly). Of the 41 respondents (45%) who now performed robotic surgery (mean 3.8 cases monthly) 39 (95%) thought that the course experience had helped with the transition into robotic surgery. Overall survey respondents were pleased with the experience during the course with 89 of 91 (98%) stating that they would recommend the course to a colleague. CONCLUSIONS: Long-term results reveal that the American Urological Association Mentored Laparoscopy Course attendees reported expansion in their laparoscopic practice since taking the course. They described the course as benefiting the transition to robotic surgery.
Asunto(s)
Competencia Clínica , Laparoscopía/educación , Urología/educación , Adulto , Educación Médica Continua , Humanos , RobóticaRESUMEN
BACKGROUND: Postprostatectomy adjuvant or salvage radiotherapy, when using standard fractionation, requires 6.5 to 8 weeks of treatment. The authors report on the safety and efficacy of an expedited radiotherapy course for salvage prostate radiotherapy. METHODS: A total of 108 consecutive patients were treated with salvage radiation therapy to 65 grays (Gy) in 26 fractions of 2.5 Gy. Median follow-up was 32.4 months. Median presalvage prostate-specific antigen (PSA) was 0.44 (range, 0.05-9.50). Eighteen (17%) patients received androgen deprivation after surgery or concurrently with radiation. RESULTS: The actuarial freedom from biochemical failure for the entire group at 4 years was 67% ± 5.3%. An identical 67% control rate was seen at 5 years for the first 50 enrolled patients, whose median follow-up was longer at 43 months. One acute grade 3 genitourinary toxicity occurred, with no acute grade 3 gastrointestinal and no late grade 3 toxicities observed. On univariate analysis, higher Gleason score (P = .006), PSA doubling time ≤12 months (P = .03), perineural invasion (P = .06), and negative margins (P = .06) showed association with unsuccessful salvage. On multivariate analysis, higher Gleason score (P = .057) and negative margins (P = .088) retained an association with biochemical failure. CONCLUSIONS: Hypofractionated radiotherapy (65 Gy in 2.5 Gy fractions in about 5 weeks) reduces the length of treatment by from 1-½ to 3 weeks relative to other treatment schedules commonly used, produces low rates of toxicity, and demonstrates encouraging efficacy at 4 to 5 years. Hypofractionation may provide a convenient, resource-efficient, and well-tolerated salvage approach for the estimated 20,000 to 35,000 US men per year experiencing biochemical recurrence after prostatectomy.